Argenx Se (ARGX) EPS (Basic) Growth (3y) (2019 - 2026)
Powered by 
Analysis
Argenx Se (ARGX) EPS (Basic) Growth (3y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 6.85% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 11.71% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 86.03% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 18.44% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.21% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 36.73% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -38.31% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 67.51% |
| 10 | Incyte | 25.44 Bn | 20.91 Bn | 1.57 Bn | 47.44% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 86.03% |
| Mar 31, 2026 | 136.61% |
| Dec 31, 2025 | 142.41% |
| Sep 30, 2025 | 48.12% |
| Jun 30, 2025 | 44.27% |
| Mar 31, 2025 | 38.12% |
| Dec 31, 2024 | 68.43% |
| Sep 30, 2024 | 32.21% |
| Jun 30, 2024 | -39.37% |
| Mar 31, 2024 | -39.39% |
| Dec 31, 2023 | -27.55% |
| Sep 30, 2023 | 34.44% |
| Jun 30, 2023 | 40.30% |
| Mar 31, 2023 | -30.43% |
| Dec 31, 2022 | 35.49% |
| Sep 30, 2022 | -101.99% |
| Jun 30, 2022 | -33.12% |
| Mar 31, 2022 | -173.22% |
| Dec 31, 2021 | -68.39% |
| Sep 30, 2021 | -88.07% |